Neurocrine Biosciences, Inc. is a company in the U.S. stock market and it is a holding in 93 U.S.-traded ETFs. NBIX has around 6.6M shares in the U.S. ETF market. The largest ETF holder of NBIX is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 950.92K shares. Investors may also find of interest that the ETF with the largest allocation to NBIX stock is Direxion Fallen Knives ETF (NIFE), with a portfolio weight of 5.45%. On average, U.S. ETFs allocate 0.49% of NBIX to their portfolios.
Additionally, NBIX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NBIX as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.